© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
OTTAWA, CANADA--(Marketwired - July 8, 2015) - DragonWave Inc. (TSX:DWI)(NASDAQ: DRWI) a leading global supplier of packet microwave radio systems for mobile and access networks, today announced financial results for the first quarter of fiscal year 2016. All figures are in U.S. dollars and were prepared in accordance with U.S. generally accepted accounting principles ("GAAP").
Revenue for the first quarter of fiscal year 2016 was $26.3 million, compared with $43.7 million in the fourth quarter of fiscal year 2015 and $28.8 million in the first quarter of fiscal year 2015. Revenue from the Nokia channel represented 52% of revenue in the first quarter of this fiscal year, versus 46% in the fourth quarter of fiscal year 2015 and 61% in first quarter of fiscal year 2015.
Gross profit in the first quarter of fiscal year 2016 was 21.1%, compared with 19.4% in the fourth quarter of fiscal year 2015 and 20.5% in the first quarter of fiscal year 2015.
Net loss attributable to shareholders in the first quarter of fiscal year 2016 was ($6.0) million or ($0.08) per basic and diluted share. This compares to a net loss attributable to shareholders of ($2.3) million or ($0.03) per basic and diluted share in the fourth quarter of fiscal year 2015 and ($6.6) million or ($0.11) per basic and diluted share in the first quarter of fiscal year 2015.
Key achievements in the quarter include:
-- DragonWave Harmony Enhanced solution selected for 3G/4G network in
India;
-- Scaled the manufacturing run rate of our Harmony Enhanced product in
response to strong market demand;
-- Received additional multi-million dollar turnkey purchase orders from
pan-India broadband service provider;
-- Received first small-cell order for another Tier 1 North American
carrier; and
-- Small cell trial activity is increasing with fifteen active trials
worldwide.
CONSOLIDATED BALANCE SHEETS
Expressed in US $000's except share amounts
(Unaudited)
As at As at
May 31, February 28,
2015 2015
--------------------------------------
Assets
Current Assets
Cash and cash equivalents 18,908 23,692
Trade receivables 35,925 48,626
Inventory 35,133 24,294
Other current assets 4,708 5,834
Deferred tax asset 61 61
--------------------------------------
94,735 102,507
Long Term Assets
Property and equipment 4,671 4,322
Deferred tax asset 1,473 1,485
Deferred financing cost 5 18
Intangible assets 776 794
Goodwill 11,927 11,927
--------------------------------------
18,852 18,546
Total Assets 113,587 121,053
--------------------------------------
--------------------------------------
Liabilities
Current Liabilities
Accounts payable and accrued
liabilities 37,506 40,163
Deferred revenue 858 830
Capital lease obligation 583 514
--------------------------------------
38,947 41,507
Long Term Liabilities
Debt facility 33,700 32,400
Other long term liabilities 990 1,139
Warrant liability 717 1,239
--------------------------------------
35,407 34,778
Shareholders' equity
Capital stock 220,968 220,952
Contributed surplus 8,661 8,388
Deficit (181,875) (175,921)
Accumulated other comprehensive loss (9,618) (9,618)
--------------------------------------
Total Shareholders' equity 38,136 43,801
Non-controlling interests 1,097 967
--------------------------------------
Total Equity 39,233 44,768
Total Liabilities and Equity 113,587 121,053
--------------------------------------
--------------------------------------
Shares issued & outstanding 75,315,330 75,290,818
CONSOLIDATED STATEMENTS OF OPERATIONS
Expressed in US $000's except share and per share amounts
(Unaudited)
Three months ended
May 31, May 31,
2015 2014
--------------------------------------
REVENUE 26,340 28,771
Cost of sales 20,791 22,885
--------------------------------------
Gross profit 5,549 5,886
--------------------------------------
EXPENSES
Research and development 3,885 4,265
Selling and marketing 3,244 3,365
General and administrative 3,834 4,426
--------------------------------------
10,963 12,056
--------------------------------------
Loss before amortization of intangible
assets and other items (5,414) (6,170)
Amortization of intangible assets (183) (309)
Accretion expense (71) (40)
Interest expense (531) (425)
Gain on change in estimate - 101
Fair value adjustment - warrant
liability 522 150
Foreign exchange (loss) gain (80) 121
--------------------------------------
Loss before income taxes (5,757) (6,572)
Income tax expense 67 95
--------------------------------------
Net Loss (5,824) (6,667)
Net (Income) Loss Attributable to
Non-Controlling Interest (130) 35
--------------------------------------
Net Loss attributable to shareholders (5,954) (6,632)
Net loss per share
Basic (0.08) (0.11)
Diluted (0.08) (0.11)
Weighted Average Shares Outstanding
Basic 75,298,537 58,194,153
Diluted 75,298,537 58,194,153